1. Home
  2. CHPG vs LUCD Comparison

CHPG vs LUCD Comparison

Compare CHPG & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHPG
  • LUCD
  • Stock Information
  • Founded
  • CHPG 2024
  • LUCD 2018
  • Country
  • CHPG United States
  • LUCD United States
  • Employees
  • CHPG N/A
  • LUCD N/A
  • Industry
  • CHPG
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CHPG
  • LUCD Health Care
  • Exchange
  • CHPG Nasdaq
  • LUCD Nasdaq
  • Market Cap
  • CHPG 101.2M
  • LUCD 108.0M
  • IPO Year
  • CHPG N/A
  • LUCD 2021
  • Fundamental
  • Price
  • CHPG $10.16
  • LUCD $1.03
  • Analyst Decision
  • CHPG
  • LUCD Strong Buy
  • Analyst Count
  • CHPG 0
  • LUCD 4
  • Target Price
  • CHPG N/A
  • LUCD $3.88
  • AVG Volume (30 Days)
  • CHPG 10.4K
  • LUCD 598.7K
  • Earning Date
  • CHPG 07-23-2025
  • LUCD 11-12-2025
  • Dividend Yield
  • CHPG N/A
  • LUCD N/A
  • EPS Growth
  • CHPG N/A
  • LUCD N/A
  • EPS
  • CHPG N/A
  • LUCD N/A
  • Revenue
  • CHPG N/A
  • LUCD $4,399,000.00
  • Revenue This Year
  • CHPG N/A
  • LUCD $13.30
  • Revenue Next Year
  • CHPG N/A
  • LUCD $155.58
  • P/E Ratio
  • CHPG N/A
  • LUCD N/A
  • Revenue Growth
  • CHPG N/A
  • LUCD 5.01
  • 52 Week Low
  • CHPG $9.81
  • LUCD $0.75
  • 52 Week High
  • CHPG $10.24
  • LUCD $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CHPG N/A
  • LUCD 37.78
  • Support Level
  • CHPG N/A
  • LUCD $1.04
  • Resistance Level
  • CHPG N/A
  • LUCD $1.10
  • Average True Range (ATR)
  • CHPG 0.00
  • LUCD 0.06
  • MACD
  • CHPG 0.00
  • LUCD -0.01
  • Stochastic Oscillator
  • CHPG 0.00
  • LUCD 2.38

About CHPG ChampionsGate Acquisition Corporation Class A Ordinary Share

Championsgate Acquisition Corp is a blank check company.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: